| Transaction approval | Shareholders may challenge a merger, sale, or other control transaction, alleging inadequate disclosure, conflicts of interest, or an unfair process. | A court or regulator may review the process; a dispute can create uncertainty around approval, closing, or transaction terms. Outcomes depend on the applicable law and facts. | Review shareholder notices, meeting materials, board records, fairness analyses, and any pending claims. Confirm required approvals in each relevant jurisdiction. |
| Disclosure and representations | Claims may allege that material information about the company or transaction was omitted or misstated. | Disputes can affect the reliability of deal information, lead to additional disclosure, and prompt questions about contractual representations and indemnities. | Compare disclosures across filings and transaction documents. Identify unresolved allegations and assess how they relate to representations, covenants, and closing conditions. |
| Closing timetable | Litigation may seek an injunction or other court order that could restrict a shareholder vote or transaction step. | Proceedings, hearings, or interim orders can delay the transaction. The timing and availability of relief vary by court and jurisdiction. | Map procedural milestones against the deal timetable. Include appropriate contingency planning and confirm whether any order affects a required closing step. |
| Valuation and deal certainty | Shareholders may dispute the consideration, valuation method, or conduct of the sale process. | A challenge may increase scrutiny of the transaction rationale and process, creating uncertainty for financing, approvals, or stakeholder expectations. | Examine valuation support, alternatives considered, conflicts management, and the record of the sale process. Distinguish allegations from established findings. |
| Governance and conflicts | Claims may concern directors’ duties, related-party dealings, or the handling of competing interests. | Governance disputes can complicate decision-making and require closer review of who had authority to approve the transaction. | Review board and committee minutes, conflict disclosures, recusals, and approval procedures under the applicable corporate law. |
| Multi-jurisdiction exposure | Shareholders, issuers, and transaction parties may be connected to different countries, each with its own court procedures and securities rules. | Related claims or regulatory inquiries may proceed in more than one jurisdiction, with different standards, remedies, and timetables. | Identify where claims are filed and which laws may apply. Obtain jurisdiction-specific advice on service, recognition of orders, and parallel proceedings. |
| Transaction costs and resources | Responding to claims can require document preservation, legal advice, witness preparation, and management attention. | These demands may add costs and divert resources during negotiations, integration planning, or other deal work. | Assess known claims and expected response obligations. Clarify responsibility for litigation costs and cooperation in the transaction documents. |
| Post-closing exposure | Some claims may continue after closing, depending on the claim, governing law, procedural posture, and transaction structure. | The buyer may face ongoing information requests, litigation-related obligations, or disputes over risk allocation, even if the transaction has closed. | Review survival periods, indemnities, conduct-of-claims provisions, access to records, and any arrangements for cooperation after closing. |